Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyzine for Prevention of Pruritus and Nausea/Vomiting from Spinal Morphine
NCT01055236Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydroxyzine in pruritus, nausea ((none)) and Vomiting (2 arms), sponsored by Mahidol University. Primary endpoint: Successful treatment of pruritus at 48 hours. Started Aug 2007; status: completed.
02
Drugs
hydroxyzine
03
Conditions
pruritusnausea ((none))Vomiting
Beyond the preview
Go deeper on NCT01055236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055236.